No Data
JMP Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $20
Express News | Terns Pharmaceuticals: On Track to Initiate Tern-601 Phase 2 Falcon Study in Early 2Q25 With 12-Week Data Expected 2H25
Express News | Terns Pharmaceuticals: Cash & Cash Equivalents Expected to Provide Runway Into 2028
Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference
Terns Pharmaceuticals Appoints Andrew Gengos as Chief Fincl Officer >TERN
Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer
iluvpoptarts : ty much. I owe you a good joke when you're ready
manukahoney : when will CCTG pump occur? pre market today?
Jaguar8 OP manukahoney : it already started pumping Friday AH
manukahoney Jaguar8 OP : is it too late if i pump today during pre market sir?
Arrayfunction : This is probably an unknowable question - but logically, the massive cuts at NIH and NSF are going to stall out the biotech industry with what.....an 8-10 year lag? I know they don't tend to fund private clinical trials all that often, but they are shutting the tap off at the academic institutions that come up with the molecules that biotech/pharma buys the rights to?